Substituted 1,4-benzodiazepine-2,5-diones As Alpha-helix Mimetic Antagonists of the HDM2-p53 Protein-protein Interaction
Overview
Pharmacology
Authors
Affiliations
Small molecule antagonists of protein-protein interactions represent a particular challenge for pharmaceutical discovery. One approach to finding molecules that can disrupt these interactions is to seek mimics of common protein structure motifs. We present an analysis of how molecules based on the 1,4-benzodiazepine-2,5-dione scaffold serve to mimic the side-chains presented by the hydrophobic face of two turns of an alpha-helix derived from the tumor suppressor protein p53, and thus antagonize the HDM2-p53 protein-protein binding interaction.
Yoo J, Choi Y, Kim H, Park S Acc Chem Res. 2024; 57(22):3254-3265.
PMID: 39480992 PMC: 11580176. DOI: 10.1021/acs.accounts.4c00452.
Wang J, Qiao C, Xiao H, Lin Z, Li Y, Zhang J Drug Des Devel Ther. 2016; 10:4091-4100.
PMID: 28008232 PMC: 5170619. DOI: 10.2147/DDDT.S118457.
The role of p53 in cancer drug resistance and targeted chemotherapy.
Hientz K, Mohr A, Bhakta-Guha D, Efferth T Oncotarget. 2016; 8(5):8921-8946.
PMID: 27888811 PMC: 5352454. DOI: 10.18632/oncotarget.13475.
Chemical Variations on the p53 Reactivation Theme.
Ribeiro C, Rodrigues C, Moreira R, Santos M Pharmaceuticals (Basel). 2016; 9(2).
PMID: 27187415 PMC: 4932543. DOI: 10.3390/ph9020025.
Multi-Facial, Non-Peptidic α-Helix Mimetics.
Lanning M, Fletcher S Biology (Basel). 2015; 4(3):540-55.
PMID: 26404384 PMC: 4588149. DOI: 10.3390/biology4030540.